ロード中...
Intravenous tPA Therapy Does Not Worsen Acute Intracerebral Hemorrhage in Mice
Tissue plasminogen activator (tPA) is the only FDA-approved treatment for reperfusing ischemic strokes. But widespread use of tPA is still limited by fears of inadvertently administering tPA in patients with intracerebral hemorrhage (ICH). Surprisingly, however, the assumption that tPA will worsen I...
保存先:
| 主要な著者: | , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2013
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3568130/ https://ncbi.nlm.nih.gov/pubmed/23408937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0054203 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|